RBC Capital analyst Conor McNamara maintained a Buy rating on Illumina (ILMN – Research Report) on October 23 and set a price target of $252.00. The company’s shares closed yesterday at $141.39.
Canaccord Genuity analyst Kyle Mikson CFA maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $130.00. Kyle Mikson CFA has given his Hold rating due to a ...
Abstract: The Charge Coupled Device (CCD) scanner determines the concentration of the microarray by capturing the intensity of the fluorescent signal on the microarray in combination with the standard ...
Heart failure with preserved ejection fraction is a major global public health problem, while effective risk stratification tools are still lacking. We sought to construct a multi-mRNA signature to ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...
MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen introduces a new high-resolution scanning instrument, the NimbleGen MS 200 Microarray Scanner. The MS 200 is the first scanner optimized to reveal the ...
Abstract: In this paper, the fluorescence detection of microarray is analyzed. The guidelines for optical system of microarray scanner based on CCD is proposed. A novel CCD-based microarray scanner ...